Makena, previously called Gestiva, has faced years of delays at the FDA, which issued an "approvable" letter for the drug in October 2006, but delayed further action in January 2009. The agency requested more information on the dr
Hologic (HOLX) is down fractionally in choppy trade around the even mark, after announcing today that its drug, Makena, designed to prevent premature birth, was approved by the U.S. Food and Drug Administration, but it added that
